Kynam Capital Management, LP

Holdings History for Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT)

Symbol: COGT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned: 6,165,223 shares
Security Ownership %: 4.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Kynam Capital Management, LP ownership in Cogent Biosciences, Inc. Common Stock, $0.001 par value per share (COGT)

17 Feb 2026 - Kynam Capital Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,165,223 shares of Cogent Biosciences, Inc. Common Stock, $0.001 par value per share (COGT). This represents 4.3% ownership of the company. In their previous filing dated 14 Nov 2025, Kynam Capital Management, LP had reported owning 7,886,172 shares, indicating a decrease of +22%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Kynam Capital Management, LP	4.3%	-20%	$219,296,982	6,165,223	-1,720,949	-22%	$35.57	13G/A	31 Dec 2025	17 Feb 2026, 12:43
Kynam Capital Management, LP	5.5%		$113,245,430	7,886,172			$14.36	13G/A	30 Sep 2025	14 Nov 2025, 12:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	14%	-4%	$218,988,721	6,165,223	-1,720,949	-22%	$35.52	Q4 2025
30 Sep 2025	8.4%	-0.65%	$113,245,430	7,886,172	-606,385	-7.1%	$14.36	Q3 2025
30 Jun 2025	6.6%	-0.47%	$60,976,559	8,492,557	-612,443	-6.7%	$7.18	Q2 2025
31 Mar 2025	4.7%	0%	$54,538,950	9,105,000	0		$5.99	Q1 2025
31 Dec 2024	4.7%	-0.07%	$71,019,000	9,105,000	-134,731	-1.5%	$7.80	Q4 2024
30 Sep 2024	7.7%	-0.02%	$99,789,095	9,239,731	-20,654	-0.22%	$10.80	Q3 2024
30 Jun 2024	8.2%	+0.71%	$78,065,046	9,260,385	+760,385	+8.9%	$8.43	Q2 2024
31 Mar 2024	6.4%	+2%	$57,120,000	8,500,000	+2,645,234	+45%	$6.72	Q1 2024
31 Dec 2023	3.9%	+2.4%	$34,426,024	5,854,766	+3,644,641	+165%	$5.88	Q4 2023
30 Sep 2023	3.6%	+0.96%	$21,548,719	2,210,125	+592,734	+37%	$9.75	Q3 2023
30 Jun 2023	2.9%	+2.2%	$19,149,909	1,617,391	+1,217,417	+304%	$11.84	Q2 2023
31 Mar 2023	0.56%	-0.55%	$4,315,719	399,974	-394,075	-50%	$10.79	Q1 2023
31 Dec 2022	1.4%	-0.34%	$9,179,206	794,049	-191,106	-19%	$11.56	Q4 2022
30 Sep 2022	3.2%	-0.05%	$14,699,000	985,155	-14,845	-1.5%	$14.92	Q3 2022
30 Jun 2022	2.3%	+2.3%	$9,020,000	1,000,000	+1,000,000	NEW	$9.02	Q2 2022
31 Mar 2022		-0.69%	$0	0	-150,000	-100%	$37.79	Q1 2022
31 Dec 2021	0.69%	0%	$1,287,000	150,000	0		$8.58	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.